Avidity Biosciences Inc (RNA)
25.58 +1.47 (+6.10%) 04/11/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 25.58 unch (unch) 04/11/25
for Fri, Apr 11th, 2025
Results
download Want to compare other data? Select Fields| Symbol | RNA | RARE | MRUS | ||
| Company | Avidity Biosciences Inc | Ultragenyx Pharmaceu | Merus N.V. CS | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 24.04 | 33.17 | 38.70 | ||
| High | 25.80 | 34.50 | 42.12 | ||
| Low | 23.66 | 32.41 | 38.19 | ||
| Last | 25.58 | 34.14 | 41.97 | ||
| Change | +1.47 | +0.98 | +3.35 | ||
| % Change | +6.10% | +2.96% | +8.67% | ||
| Volume | 1,550,200 | 1,103,500 | 832,200 | ||
| 20-Day Average Volume | 1,885,810 | 905,130 | 849,805 | ||
| Previous Close | 24.11 | 33.16 | 38.62 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 29.20 | 36.32 | 43.14 | ||
| 20-Day Raw Stochastic | 32.33% | 42.86% | 52.86% | ||
| 20-Day Relative Strength | 41.75% | 40.56% | 48.22% | ||
| Weighted Alpha | -30.05 | -34.45 | -16.92 | ||
| Today's Opinion | 100% Sell | 100% Sell | 88% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 72% Sell | ||
| Last Month's Opinion | 64% Sell | 100% Sell | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.73% since 04/04/25 | +5.27% since 04/04/25 | +10.13% since 04/04/25 | ||
| Low | 21.51 on 04/09/25 | 29.59 on 04/09/25 | 33.19 on 04/09/25 | ||
| High | 27.83 on 04/08/25 | 34.50 on 04/11/25 | 42.12 on 04/11/25 | ||
| 1-Month | |||||
| %Chg | -13.52% since 03/11/25 | -10.93% since 03/11/25 | -11.79% since 03/11/25 | ||
| Low | 21.51 on 04/09/25 | 29.59 on 04/09/25 | 33.19 on 04/09/25 | ||
| High | 36.38 on 03/13/25 | 40.53 on 03/13/25 | 49.88 on 03/13/25 | ||
| 3-Month | |||||
| %Chg | -13.17% since 01/10/25 | -18.85% since 01/10/25 | -4.29% since 01/10/25 | ||
| Low | 21.51 on 04/09/25 | 29.59 on 04/09/25 | 33.19 on 04/09/25 | ||
| High | 36.38 on 03/13/25 | 46.50 on 02/06/25 | 49.88 on 03/13/25 | ||
| 6-Month | |||||
| %Chg | -45.11% since 10/11/24 | -38.04% since 10/11/24 | -21.40% since 10/11/24 | ||
| Low | 21.51 on 04/09/25 | 29.59 on 04/09/25 | 33.19 on 04/09/25 | ||
| High | 56.00 on 11/13/24 | 57.99 on 10/16/24 | 55.39 on 11/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,075,023 | 3,205,507 | 2,899,707 | ||
| Shares Outstanding, K | 120,212 | 93,893 | 69,090 | ||
| Annual Sales | 10,900,000 | 560,230,000 | 36,130,000 | ||
| Annual Net Income | -322,300,000 | -569,180,000 | -215,330,000 | ||
| Last Quarter Sales | 2,970,000 | 164,880,000 | 9,140,000 | ||
| Last Quarter Net Income | -102,260,000 | -133,390,000 | -30,920,000 | ||
| 60-Month Beta | 1.01 | 0.61 | 1.02 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.80 on 02/27/25 | -1.39 on 02/13/25 | -0.41 on 02/27/25 | ||
| Latest Earnings Date | 05/08/25 | 05/01/25 | 05/14/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||